Pharmaceutical composition for treating acute myeloid leukemia or myelodysplastic syndrome or composition for predicting the relapse risk of acute myeloid leukemia or myelodysplastic syndrome

摘要

The present invention relates to a pharmaceutical composition for the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), and a composition for predicting the risk of recurrence of acute myeloid leukemia or myelodysplastic syndrome. The pharmaceutical composition of the present invention has an excellent therapeutic effect on acute myeloid leukemia or myelodysplastic syndrome. In addition, the pharmaceutical composition of the present invention can be usefully used to prevent recurrence of acute myeloid leukemia or myelodysplastic syndrome. In addition, the composition of the present invention can be efficiently used to simply diagnose the prognosis for an individual's acute myeloid leukemia or myelodysplastic syndrome, or the risk of recurrence of acute myeloid leukemia or myelodysplastic syndrome.